WARNING: CannTrust (TSX:TRST) Could Be De-listed From the TSX. Avoid This Stock!

No matter how forgiving you might feel with the New Year around the corner, CannTrust is a stock you should avoid like the plague right now.

With holiday season approaching, you might want to take a good look at your investment portfolio to see what you can do to change things up a little bit. A lot has happened over the past 12 months, with the legal cannabis sector, which was legalized in October 2018, being a particular area of investors’ interest.

The legal marijuana industry showed a lot of promise, but it hit quite a few snags on its way. The entire sector is down by a significant margin since its all-time highs some time back. One of the notable incidents that rocked the whole industry is the scandal involving CannTrust Holdings (TSX:TRST)(NYSE:CTST).

What happened?

If you do not know about it already, I will give you a precise account of what happened. Regulatory bodies like Health Canada regulate the legal cannabis industry. Authorities want to make sure that all of the products entering the market to reach consumers are controlled, safe, and compliant with legal and health standards.

The reason the illegal industry continues to boom is that it faces no regulatory restrictions or quality control standards. Unlicensed sellers can sell their goods at lower prices, affecting the legal industry’s market share by a significant margin.

Enter CannTrust Holdings as the would-be saviour of the legal marijuana industry. In an attempt to revitalize its line of products, the company was growing black market weed in secret rooms within its facilities. CannTrust got caught in the act, so it is safe to say that many people do not trust CannTrust anymore. The CEO was fired, regulators have been busy scrutinizing the company’s financial documents, and now exchanges are threatening to take the company’s stocks off the board.

CannTrust might be down and out

In light of the scandal, Health Canada allowed the company to make amends for its actions. Regulatory bodies have offered CannTrust until March 25, 2020, to file its audited financial restatements for the year 2018. If the company fails to do so, the Toronto Stock Exchange might finally de-list CannTrust. Trading at $1.03 per share, TRST stock might end up amounting to nothing at all.

A financial restatement is something that publicly traded companies need to file when authorities find a company conducting questionable activity and misreporting its financial data. The trouble started for CannTrust when regulators discovered secret grow rooms in its facilities towards the end of 2018.

Health Canada suspended CannTrust’s licence to produce and distribute marijuana in October 2019. The company also lost $77 million, as it had to discard inventory since it was not possible to determine how much of it was even legally grown. To save money, the company ended up laying off around 140 employees.

Foolish takeaway

There is very little I should need to say about CannTrust in light of all this information. CannTrust announced on November 26, 2019, that the TSX might de-list its shares. If you own any shares of the company even now, my advice would be to take whatever you have left and invest it elsewhere. Likely, the stock will completely tank when March 2020 comes.

Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool recommends CannTrust Holdings and CannTrust Holdings Inc.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »